{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:25:20Z","timestamp":1786119920657,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/inf.0b013e3182253c54","type":"journal-article","created":{"date-parts":[[2011,6,23]],"date-time":"2011-06-23T07:39:25Z","timestamp":1308814765000},"page":"992-995","source":"Crossref","is-referenced-by-count":14,"title":["Mitochondrial Impact of Human Immunodeficiency Virus and Antiretrovirals on Infected Pediatric Patients With or Without Lipodystrophy"],"prefix":"10.1097","volume":"30","author":[{"given":"Constanza","family":"Mor\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Noguera-Julian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00f2ria","family":"Garrabou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Nicol\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Tob\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Cardellach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d2scar","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e0udia","family":"Fortuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210202","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.","volume":"346","author":"C\u00f4t\u00e9","year":"2002","journal-title":"N Engl J Med"},{"key":"R2-19-20210202","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1128\/AAC.46.8.2687-2691.2002","article-title":"Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor.","volume":"46","author":"Pilon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R3-19-20210202","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/brain\/119.4.1357","article-title":"The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction.","volume":"119","author":"Casademont","year":"1996","journal-title":"Brain"},{"key":"R4-19-20210202","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","article-title":"Mitochondrial myopathy caused by long-term zidovudine therapy.","volume":"322","author":"Dalakas","year":"1990","journal-title":"New Engl J Med"},{"issue":"suppl 2","key":"R5-19-20210202","article-title":"Nucleoside analogues toxicities relate to mitochondrial dysfunction: focus on HIV-infected children.","volume":"10","author":"Vigan\u00f2","year":"2005","journal-title":"Antivir Ther"},{"key":"R6-19-20210202","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molmed.2010.03.002","article-title":"HIV-associated lipodystrophy: from fat injury to premature aging.","volume":"16","author":"Caron-Debarle","year":"2010","journal-title":"Trends Mol Med"},{"key":"R7-19-20210202","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00126334-200301010-00007","article-title":"Incidence of and risk factor for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients.","volume":"32","author":"Lichtenstein","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-19-20210202","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"R9-19-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/11532520-000000000-00000","article-title":"Impact on antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.","volume":"12","author":"Kim","year":"2010","journal-title":"Paediatr Drugs"},{"key":"R10-19-20210202","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1128\/AAC.00893-07","article-title":"Impact of nucleoside reverse transcriptase inhibitors on mitochondrial in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.","volume":"51","author":"Saitoh","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-19-20210202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/INF.0b013e31814689be","article-title":"Effects of the change from stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function.","volume":"27","author":"Rosso","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R12-19-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/338564","article-title":"Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antirretroviral therapy- related lipodystrophy.","volume":"185","author":"Cossarizza","year":"2002","journal-title":"J Infect Dis"},{"key":"R13-19-20210202","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding.","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"R14-19-20210202","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1097\/00126334-200412150-00002","article-title":"Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.","volume":"37","author":"Mir\u00f3","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"suppl 5","key":"R16-19-20210202","first-page":"38","article-title":"Sysregulation of lipid turnover is a key defect in the HIV lipodystrophy syndrome.","volume":"5","author":"Sekhar","year":"2000","journal-title":"Antivir Ther"},{"key":"R17-19-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/QAD.0b013e3283423219","article-title":"Mitochondrial damage in adipose tissue of untreated HIV-infected patients.","volume":"25","author":"Garrabou","year":"2011","journal-title":"AIDS"},{"key":"R18-19-20210202","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/aid.2010.0024","article-title":"Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study.","volume":"26","author":"Milazzo","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R19-19-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/aid.2009.0273","article-title":"Evolution of mitochondrial DNA content after planned treatment interruption of HIV-infected pediatric patients.","volume":"26","author":"Noguera","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R21-19-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GIM.0b013e3181632713","article-title":"IL-1beta (+3954C\/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.","volume":"10","author":"Asensi","year":"2008","journal-title":"Genet Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201111000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:30:12Z","timestamp":1786044612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201111000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3182253c54","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}